FDA 483 - Sun Pharmaceutical Medicare Ltd. - September 08, 2025

I am unable to provide a concise summary of the FDA 483 document as the provided content is entirely redacted, marked as "(b) (4)". This redaction prevents the identification of the company name, inspection dates, main violations, relevant regulatory framework, and any required actions, which are all essential elements for creating the requested summary. Without the document's content, a meaningful summary cannot be generated.